Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303). [electronic resource]
Producer: 20150611Description: 2036-2041 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Carboplatin -- administration & dosage
- Cetuximab
- Chemoradiotherapy
- Disease-Free Survival
- Drug-Related Side Effects and Adverse Reactions -- pathology
- Epithelial Cells -- drug effects
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Male
- Middle Aged
- Neoplasm Staging
- Paclitaxel -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.